EP0486638A1 - Method for fabricating a lens made of transparent polymer with modulated refraction index. - Google Patents
Method for fabricating a lens made of transparent polymer with modulated refraction index.Info
- Publication number
- EP0486638A1 EP0486638A1 EP91910305A EP91910305A EP0486638A1 EP 0486638 A1 EP0486638 A1 EP 0486638A1 EP 91910305 A EP91910305 A EP 91910305A EP 91910305 A EP91910305 A EP 91910305A EP 0486638 A1 EP0486638 A1 EP 0486638A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- lens
- monomer
- irradiation
- photoinitiator
- mask
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 42
- 229920000642 polymer Polymers 0.000 title description 13
- 239000000178 monomer Substances 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 29
- 239000000017 hydrogel Substances 0.000 claims abstract description 16
- 230000008569 process Effects 0.000 claims abstract description 15
- 230000003287 optical effect Effects 0.000 claims abstract description 11
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 7
- 230000008961 swelling Effects 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 4
- 238000000638 solvent extraction Methods 0.000 claims abstract description 3
- 239000003999 initiator Substances 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000005470 impregnation Methods 0.000 claims description 10
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 8
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 7
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 6
- 239000007943 implant Substances 0.000 claims description 5
- 201000010041 presbyopia Diseases 0.000 claims description 5
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 4
- 201000009310 astigmatism Diseases 0.000 claims description 4
- 229920005601 base polymer Polymers 0.000 claims description 4
- 238000012937 correction Methods 0.000 claims description 4
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims description 3
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 claims description 3
- 239000012190 activator Substances 0.000 claims description 3
- 239000003431 cross linking reagent Substances 0.000 claims description 3
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 2
- 238000000354 decomposition reaction Methods 0.000 claims description 2
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 2
- MZGMQAMKOBOIDR-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCO MZGMQAMKOBOIDR-UHFFFAOYSA-N 0.000 claims 1
- 102100026735 Coagulation factor VIII Human genes 0.000 claims 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 claims 1
- 238000004132 cross linking Methods 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 239000003211 polymerization photoinitiator Substances 0.000 claims 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 12
- -1 hydroxyalkyl methacrylates Chemical class 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 239000012965 benzophenone Substances 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001851 biosynthetic effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 3
- 229910052753 mercury Inorganic materials 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- ZGRQPKYPJYNOKX-XUXIUFHCSA-N Cys-Cys-His-His Chemical compound C([C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CS)N)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 ZGRQPKYPJYNOKX-XUXIUFHCSA-N 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- NEDJKVIUOSOCNB-AWPSVMBFSA-N [(6s,8r,9s,10r,13s,14s,17r)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] acetate;[(8r,9s,13s,14s,17s)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclo Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21.O([C@H]1CC[C@H]2[C@H]3[C@@H](C4=CC=C(O)C=C4CC3)CC[C@@]21C)C(=O)CCC1CCCC1 NEDJKVIUOSOCNB-AWPSVMBFSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 208000017983 photosensitivity disease Diseases 0.000 description 2
- 231100000434 photosensitization Toxicity 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- IISHLYLZTYTIJJ-UHFFFAOYSA-N 1-hydroxyethyl 2-methylprop-2-enoate Chemical compound CC(O)OC(=O)C(C)=C IISHLYLZTYTIJJ-UHFFFAOYSA-N 0.000 description 1
- AOIDYWIUVADOPM-UHFFFAOYSA-N 2-hydroxyethyl 2,3-dimethylbut-2-enoate Chemical compound CC(C)=C(C)C(=O)OCCO AOIDYWIUVADOPM-UHFFFAOYSA-N 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- AGBXYHCHUYARJY-UHFFFAOYSA-N 2-phenylethenesulfonic acid Chemical compound OS(=O)(=O)C=CC1=CC=CC=C1 AGBXYHCHUYARJY-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- FZEYVTFCMJSGMP-UHFFFAOYSA-N acridone Chemical class C1=CC=C2C(=O)C3=CC=CC=C3NC2=C1 FZEYVTFCMJSGMP-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000005399 allylmethacrylate group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000008425 anthrones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N desyl alcohol Natural products C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 150000008376 fluorenones Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- MPQXHAGKBWFSNV-UHFFFAOYSA-N oxidophosphanium Chemical class [PH3]=O MPQXHAGKBWFSNV-UHFFFAOYSA-N 0.000 description 1
- 238000007540 photo-reduction reaction Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- RKFCDGOVCBYSEW-AUUKWEANSA-N tmeg Chemical compound COC=1C(OC)=CC(C(OC(C=2OC)=C34)=O)=C3C=1OC(=O)C4=CC=2O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RKFCDGOVCBYSEW-AUUKWEANSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 150000007964 xanthones Chemical class 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
Definitions
- the present invention relates to techniques which make it possible to modify the optical properties of a transparent polymer, more particularly when an attempt is made to modulate the refractive index of a semi-finished article made of transparent organic material previously polymerized and put in shape, without significantly modifying its geometry or its surface condition.
- a preferred application of the invention relates to the manufacture of] enti]] es artificial optical vision correction such as contact lenses and ocular implants, since in these examples, the preservation of a given geometric shape is of great importance, as are those of surface qualities ensuring on both sides of the lens, biological compatibility with the ocular medium and the absence of eye irritation.
- Such lenses are small and intended to be used in full opening, by distinction with spectacle lenses, on the other hand that they must have a predetermined geometric shape, which, for example, for a contact lens, will be adapted to the morphology of the eye which receives them, or which will provide a basic accommodation power for a lens replacement implant.
- the modulation of the refractive index targeted by the invention may in particular aim to confer an aspherical power profile on a lens whose optical power is initially spherical or to create a diffractive network providing the bifocal ity to a contact lens or presbyopic implant. It can also help correct other vision abnormalities like astigmatism or alleviating chromatic aberration.
- the known methods involve depositing on a rigid support a liquid composition 0 comprising the base polymer in solution with the photo-polymerizable monomer, as well as a photo. -initiator capable of causing the polymerization of this monomer under irradiation.
- the deposit is then hardened by exposing it to a source of irradiation modulated in intensity, in 5 • power or exposure time, or through a mask of suitable shape, after which the uncured constituents, originating in especially areas of the film that have not been irradiated.
- the lack of stability over time of the index modulations thus obtained led
- the present invention makes it possible to avoid these drawbacks, thanks to a method of manufacturing an optical lens with refractive index modulation, characterized in that, starting from a lens of transparent hydrophilic polymer of hydrogel type, beforehand shaping, this lens is impregnated with a merishable photopoly ⁇ composition comprising at least one monomer and a photoinitiator in solution in a swelling solvent for the hydrogel, such. than an aqueous solvent, the impregnated lens is subjected to a spatially modulated irradiation in intensity and / or irradiation time, causing a local selective polymerization of the monomer, then the excess of photo-initiator and monomer is eliminated. not polymerized by solvent extraction.
- hydrogels for lenses to be used in ophthalmic medium such as hydrogels based on methyl methacrylate (MMA) and vinylpyrrolidone (NVP) or hydroxyethyl methacrylate and vinylpyrrolidone (HEMA / NVP), or polyhydroxyethyl methacrylate hydrogels, have a specific macromolecular network, which is very favorable for the good distribution and stability of an interpenetrating polymer network formed within it by the index modulation method of the invention.
- the first step consists in immersing the hydrogel, preferably in the already hydrated state, in an aqueous solution of the photopolymerizable composition, to swell the polymer with this solution. displacing the pure water it contains.
- a dry hydrogel which is then saturated directly with the treatment solution.
- the hydrophilic polymers used to constitute the basic hydrogel have water absorption capacities of 30% to 80% by volume.
- the monomer present in the imesti ⁇ gnation composition can be of the same type as those involved in the manufacture of the base material of the lens, or of a different type, it being understood that it must be soluble in the swelling solvent, more particularly water, or at least soluble in the ternary water / - monomer / photoinitiator system. In both cases, it is advantageous to choose a monomer which, after hardening of the composition where it is combined with the photoinitiator, leads to a material whose refractive index is substantially different from that of the base material of the lens, the latter being considered under its normal conditions of use, therefore in the hydrated state at saturation with water.
- an ethylene double bond monomer chosen from: alkyl acrylates and allyl methacrylates as well as their derivatives, in particular methyl methacrylate, is advantageously used; vinyl aromatic monomers and their derivatives, for example styrene; N-vinyl-lactams and their derivatives, preferably N-vinylpyrrolidone; hydroxyalkyl methacrylates such as 'ydroxyethyl methacrylate (HEMA) or' hydroxypropyl methacrylate (HPMA).
- HEMA 'ydroxyethyl methacrylate
- HPMA hydroxypropyl methacrylate
- methyl or hydroxyethyl or propyl methacrylate will be chosen.
- Such a monomer is preferably supplemented by a crosslinking agent such as a difunctional acrylate, or more particularly an alkyl dimethacrylate, in which the alkyl chain can contain in particular from 1 to 5 carbon atoms.
- a crosslinking agent such as a difunctional acrylate, or more particularly an alkyl dimethacrylate, in which the alkyl chain can contain in particular from 1 to 5 carbon atoms.
- the amount of crosslinker to be used can be determined in itself conventional according to the nature and the concentration of the monomer (s) to be crosslinked chosen.
- the monomers mentioned have very variable, and sometimes low, degrees of solubility in water, as in the case of methyl methacrylate.
- hydrogel type lenses by their nature, are capable of concentrating the monomer therein during impregnation, so that the required concentrations can be reached. using a sufficient quantity of photo ⁇ polymerizable composition, reconstituted periodically.
- _ p concentration between 0.5.10 - M and 5.10 ⁇ M, chosen in particular from the following compounds: ethylene glycol dimethacrylate (DMEG) or triethylene g ycol dimethacrylate p (TMEG), in a concentration preferably of the order of 10 , al yl methacrylate, N, N 'methylene diacrylamide, in pprrooppoorrttiiooin of the order of 10 -2 M to 2.5 or 3.10 2 M respectively.
- DMEG ethylene glycol dimethacrylate
- TMEG triethylene g ycol dimethacrylate p
- the photoinitiator present with the modulation monomer in the impregnation composition, or composition of photosensitization it may be any compound producing free radicals under irradiation, either by itself or by cooperation with a another proton donor compound. That is to say that the photoinitiators used, or photo-pomerization initiators, can be both of photocleavable type and of photoactivable type, with however a preference for those which are active to initiate the photopolymerization of the monomer for irradiation wavelengths lying in the visible or near UV range.
- a photocleavable photo-initiator comprises one or more compounds which function by directly generating one or more free radicals initiating polymerization, while a photoactivable photo-initiator is formed by a system producing such radicals by an oxidation-reduction reaction photo-assisted between a light absorbing compound and ur. donor of hydrogen or electrons both present in the system.
- a photoactivable photo-initiator is formed by a system producing such radicals by an oxidation-reduction reaction photo-assisted between a light absorbing compound and ur. donor of hydrogen or electrons both present in the system.
- photocleavable compounds known per se are chosen from alkoxyacetophenone derivatives, benzoin ethers, phosphine-oxides, benzoyl oxime derivatives.
- photoactivatable photoinitiators include a free radical-producing absorber chosen from benzophenones, benzyl.es, xanthones, anthrones, thioxanthones, fluorenones, suberones, acridones, in association with, as proton donor, a compound of the type of ethers, alcohols, amines, amino acids, or organometallic compounds.
- photoinitiators constituted by thioxan ⁇ thones carrying an ionic radical such as those of the family described in American patent US 4,791,213, the maximum absorption of which is in the range of 390 to 405 nanometers.
- the preferred photoinitiators used in the implementation of the process of the invention will be chosen from thioxanthones and benzophenones carrying an alkylamine or oxy-al ylamine radical, in the form of an amine salt.
- the first step consists in immersing the hydrogel already hydrated in an aqueous solution of the photopolymerizing composition to swell the polymer with this solution by displacing the pure water which it encloses .
- Active photo-initiators in low concentration are preferred for this, because they make it possible to avoid a variation in the modulated index across the thickness of the lens, hence the preference given according to the invention to photo-mixtures. activatable where the photo-initiator itself is associated with a proton donor compound.
- the concentration of photoinitiator in the impregnation solution is advantageously between 10 - * M and 0.5 M, and in particular of the order of 10 to 10 M, especially when it is a question of soluble thioxanthones by aqueous.
- an ethanolamine such as methyldiethanolamine (MDEA) or triethanolamine (TEA) is advantageously used as the electron donor.
- the irradiation of the next step can be carried out by any light source emitting in the sensitivity range of the photoinitiator used. It may especially be a mercury arc lamp, for the preferred photosensitization compositions. To limit the irradiation to the desired areas, it is possible to place a mask between the source and the impregnated material, or to make use of a laser beam, or to interference of beams of coherent light, or else to use a rotating mask having an appropriate opaque zone profile.
- the invention allows in particular, by printing the polymer swollen with the aqueous solution of monomer and photo-initiator through a mask with appropriate concentric lines, then development with water, to produce in a contact lens preformed to its final shape , a diffractive grating suitable for overcoming presbyopia, without causing annoying physical alteration of the lens, even at the surface, This can be done without disturbing the normal functioning of additives such as anti-aging agents. UV or dyes.
- the invention makes it possible to control the index modulation homogeneously in the thickness.
- a diffractive element can be produced by adjusting the diffracted energy in the desired power.
- the treatment for this involves a small number of steps and it is simple to implement so that the lines of different indices are formed within the matrix without resulting in lines in deformation of the surface, the possible extra thicknesses being for example only of the order of 1 to
- the contact lenses to be treated have
- the radius of curvature of the inflated lens in its form of use is generally of the order of 6 to 10 for the front face and of the order of 7 to 9 for the rear face.
- the diffractive grating obtained according to the invention occupies the central zone, over a diameter of the order of 4 to 6 mm, with a depth s 1 extending to the entire thickness of the lens, therefore of the order of 200 ⁇ m in the center and of the order of 300 to 400 ⁇ m at the edge of the zone.
- the concentric lines are spaced 0.5 to 1 mm in the center and gradually approach as one moves away radially from the center to reach a spacing of 50 to 100 ⁇ m at the edge of the zone.
- the rotating mask technique as described in French patent application 90 00679 can also be used to produce such diffractive elements within hydrogel lenses, as can the use of a fixed mask or any other modulation method spatial of the irradiation source in intensity and / or irradiation time can be used to produce an aspherical element such as those described in French patent application 90 00679 with the power and the desired power gradient.
- the technique of irradiation through a rotating mask has specific advantages when it is used in the process of the invention, for treating an ophthalmic lens in transparent hyirogel, shaped to already have a certain power profile, swollen with a solution of light-curing composition.
- This is verified in particular in the applications of the invention which consist in conferring on the lens a power profile different from the original profile, by spatial modulation.
- the refractive index which can be combined with a modulation of thickness remaining sufficiently low not to substantially modify the general geometry of origin of the lens. It is then, unlike the case of diffractive elements, to achieve a continuous modulation where the modification of the refractive index varies progressively parallel to the outer surface of the lens.
- the rotating mask makes it possible to radially adjust the variation in energy flow reaching the surface of the lens, when it has, for this purpose, for example alternately opaque and transparent sectors whose angular width varies between the center and the periphery of the lens.
- the index modulation resulting from the photopolymerization then adds a modulation of optical power to the original power profile, this being particularly useful for example to obtain from an original lens possibly with spherical power, a further aspherization as ask for prescription lenses for presbyopia.
- the rotating mask it is also possible to obtain a power profile correcting astigmatism, by modulating the angular speed of rotation of the mask according to the instantaneous angular position of the opaque zones.
- the speed variations to be imposed on the mask are then calculated according to the characteristics of the astigmatic power profile to be obtained.
- the aspherization of a lens can be obtained as well by alternately opaque and transparent sectors as mentioned above (provided that these sectors are not delimited by a rectilinear radius, but by curved lines) than by a variation in the radial width of the zones doing all around the mask following a curve determined as a function of the phase law to be obtained, expressed by the wavelength corresponding to the maximum phototopic sensitivity of the eye.
- this involves producing, by varying the flow of photopolymerization energy received during the rotation of the mask, optical powers having a difference of 0.5 to 3.5 diopters over a radial distance. of the order of 2 mm, which can be obtained in accordance with the invention by varying the exposure time in a ratio of 10 to 70 s.
- the transparent zone of the mask will start from a reference ray where it extends over the entire radial distance, to return to this reference ray tapered at a point at the periphery. If the lens has a spherical power of non-zero origin, this transparent zone will die on the reference ray at an intermediate point, so as to provide another opaque zone at the periphery.
- the light-curing impregnation base consists of a mixture of hydroxyethyl methacrylate (HEMA) and a difunctional acrylate crosslinking agent: ethylene glycol dimethylmethacrylate (DMEG) in solution in distilled water.
- HEMA hydroxyethyl methacrylate
- DMEG difunctional acrylate crosslinking agent
- the base polymer is a copolymer of methyl methacrylate and N-vinyl pyrrolidone (MMA-NVP) of the type • sold by ESSIL0R under the brand LUNELLE. It comes in semi-finished samples, in the form of optical lenses 13 to 14 mm in diameter.
- MMA-NVP N-vinyl pyrrolidone
- the photo-initiator system consists of a water-soluble thioxanthone, sold by Internationa]
- Biosynthetics under the name QUANTACURE (QTX), absorbent at 405 nm in water, of formula:
- the aqueous impregnation composition is formed of the mixture of the polymerizable base and the photo-initiator system.
- concentration ranges used are within the following limits:
- HEMA concentration between 0.6 M and 1 M
- the irradiation system consists of a high-pressure mercury arc lamp with a power of 100 W, collimated by a lens with a focal length of 200 mm.
- the flux density measured for the emission p lines at 405-408 nm is 0.75 mV7 / cm at the level of the polymer sample.
- the visible lines of mercury are selected at the level of the lamp.
- the lens is swollen in the composition comprising the photo-initiator and the polymerizing base for at least 30 minutes at room temperature.
- DMEG 10 "2 M we obtain, after 3 minutes of sunshine, an index variation of 5 x 10 " ⁇ for a lens 200 ⁇ m thick and a resolution of at least 20 ⁇ m.
- This index variation allows, among other things, to produce bifocal kinoform diffractive lenses by index variation through a suitable rotating mask
- This index variation makes it possible to produce aspherical lenses such as those described in ESSILOR patent n ° 90 00,679 with a power of 1.5 and 2 addition diopters.
- This variation in index makes it possible to produce aspherical lenses for an addition of 2.5 diopters.
- Thioxanthone is replaced by a water-soluble benzophenone, known under the name QUANTACURE BTC and developed by International Biosynthetics, with the following formula: benzophenone para- CH N® (CH Cl ⁇
- the irradiation takes place in the UV at 365 nm, corresponding to the sensitivity domain of thioxanthone.
- the photopolymerization is carried out using, for impregnating the base polymer, a mixture having the following concentrations:
- Triethanolamine (TEA) is used in place of methyl diethanolamine, as photosensitive activator of decomposition of the photoinitiator.
- the sensitization mixture has the following composition, expressed as the concentration of the constituents in water:
- a photopolymerization is obtained which makes it possible to produce a diffractive lens.
- Methyl diethanolamine is used and the QTX is replaced by another thioxanthone developed by Inter ⁇ national Biosynthetics under the name QUANTACURE ABC, of formula:
- This example relates to a formulation optimized for obtaining lenses with a variable power profile.
- the light-curing composition is an aqueous solution containing: thioxanthone HTX 5 x 10 " ⁇ M MDEA 1.2 x 10 _2 M
- Thioxanthone HTX has the formula
- a contact lens of the above type known under the name LUNELLE, spherical in the hydrated state, is immersed in the above aqueous solution for a period varying from 15 to 45 min, preferably of the order of 30 min.
- the lens is then removed from the aqueous solution and placed on a support.
- the lens is then irradiated through a rotating mask of the type shown in FIG. 1, consisting by a transparent circular disc 2 comprising two opaque symmetrical zones 1 with bulges from the center and tapered towards the periphery.
- the irradiation flux is 1.5 mW / cra2 at a wavelength of 410 nm.
- Such a mask allows to obtain an aspherical contact lens for the correction of presbyopia.
- the lens obtained does not show a power jump, as a bifocal lens would do, but a continuum.
- the shape of the mask is determined by the specific power profile that one wishes to create.
- Optimized power profiles for the correction of presbyopia are described in French patent application FR 89 01417 in the name of the applicant, published on August 10, 1990.
- the table below illustrates, as a function of the irradiation time, the addition obtained, that is to say the difference in powers between near vision (VP) and far vision (VL).
- the addition is measured using a phase difference fronto-interferometer. exposure time (seconds) 20 25 30 40
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Eyeglasses (AREA)
- Polymerisation Methods In General (AREA)
- Graft Or Block Polymers (AREA)
- Paints Or Removers (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
Abstract
La présente invention concerne un procédé de fabrication d'une lentille optique à modulation d'indice de réfraction, caractérisé en ce que, partant d'une lentille de polymère hydrophile transparent de type hydrogel, préalablement mise en forme, on imprègne cette lentille d'une composition photopolymérisable comportant au moins un monomère et un photo-initiateur en solution dans un solvant de gonflement de la lentille, on soumet la lentille imprégnée à une irradiation modulée spatialement en intensité et/ou temps d'irradiation, provoquant une polymérisation sélective locale du monomère, puis on élimine l'excédent de photo-initiateur et monomère non polymérisé par extraction au solvant.The present invention relates to a process for manufacturing an optical lens with refractive index modulation, characterized in that, starting from a lens of transparent hydrophilic polymer of the hydrogel type, shaped beforehand, this lens is impregnated with a photopolymerizable composition comprising at least one monomer and one photoinitiator in solution in a solvent for swelling the lens, the impregnated lens is subjected to irradiation spatially modulated in intensity and/or irradiation time, causing local selective polymerization of the monomer, then the excess photoinitiator and unpolymerized monomer are removed by solvent extraction.
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9005936 | 1990-05-11 | ||
FR9005936A FR2661914B1 (en) | 1990-05-11 | 1990-05-11 | METHOD FOR MANUFACTURING A TRANSPARENT POLYMER LENS WITH MODULATED REFRACTION INDEX. |
PCT/FR1991/000386 WO1991018303A1 (en) | 1990-05-11 | 1991-05-13 | Method for fabricating a lens made of transparent polymer with modulated refraction index |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0486638A1 true EP0486638A1 (en) | 1992-05-27 |
EP0486638B1 EP0486638B1 (en) | 1995-12-27 |
Family
ID=9396543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP91910305A Expired - Lifetime EP0486638B1 (en) | 1990-05-11 | 1991-05-13 | Method of manufacturing a lens made of transparent polymer with modulated refraction index |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0486638B1 (en) |
JP (1) | JP3074296B2 (en) |
AU (1) | AU635139B2 (en) |
DE (1) | DE69115861T2 (en) |
ES (1) | ES2082976T3 (en) |
FR (1) | FR2661914B1 (en) |
WO (1) | WO1991018303A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9642932B2 (en) | 2006-09-14 | 2017-05-09 | DePuy Synthes Products, Inc. | Bone cement and methods of use thereof |
US9839460B2 (en) | 2003-03-31 | 2017-12-12 | DePuy Synthes Products, Inc. | Remotely-activated vertebroplasty injection device |
US9918767B2 (en) | 2005-08-01 | 2018-03-20 | DePuy Synthes Products, Inc. | Temperature control system |
US10039585B2 (en) | 2003-06-17 | 2018-08-07 | DePuy Synthes Products, Inc. | Methods, materials and apparatus for treating bone and other tissue |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2731081B1 (en) * | 1995-02-27 | 1997-04-11 | Essilor Int | PROCESS FOR OBTAINING A TRANSPARENT ARTICLE WITH A REFRACTION INDEX |
US6450642B1 (en) * | 1999-01-12 | 2002-09-17 | California Institute Of Technology | Lenses capable of post-fabrication power modification |
US6712466B2 (en) | 2001-10-25 | 2004-03-30 | Ophthonix, Inc. | Eyeglass manufacturing method using variable index layer |
US9381024B2 (en) | 2005-07-31 | 2016-07-05 | DePuy Synthes Products, Inc. | Marked tools |
US8360629B2 (en) | 2005-11-22 | 2013-01-29 | Depuy Spine, Inc. | Mixing apparatus having central and planetary mixing elements |
CA2747850C (en) | 2006-10-19 | 2013-05-14 | Depuy Spine, Inc. | Fluid delivery system |
DE102009011838B4 (en) * | 2009-03-05 | 2017-08-31 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Optical lens and manufacturing process |
JP6500484B2 (en) * | 2015-02-19 | 2019-04-17 | 株式会社ニデック | Multifocal intraocular lens |
WO2022070600A1 (en) * | 2020-09-30 | 2022-04-07 | 富士フイルム株式会社 | Transmissive diffractive optical element, bonding optical element, intraocular lens, contact lens, and method for manufacturing transmissive diffractive optical element |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2052397C2 (en) * | 1969-12-15 | 1982-11-18 | Československá akademie věd, Praha | Process for making transparent objects made of hydrophobic organic polymers hydrophilic |
CA993401A (en) * | 1972-12-04 | 1976-07-20 | Edward W. Merrill | Contact lens and method of preparation |
US3809732A (en) * | 1972-12-18 | 1974-05-07 | Bell Telephone Labor Inc | Photo-locking technique for producing integrated optical circuits |
GB1463301A (en) * | 1973-07-18 | 1977-02-02 | Highgate D J | Polymer properties |
US3993485A (en) * | 1975-05-27 | 1976-11-23 | Bell Telephone Laboratories, Incorporated | Photopolymerization process and related devices |
US4039827A (en) * | 1976-08-26 | 1977-08-02 | American Optical Corporation | Method for marking intraocular lenses |
DE3737455A1 (en) * | 1986-11-06 | 1988-05-19 | Westinghouse Electric Corp | DEVICE AND METHOD FOR PRODUCING COLOR PATTERNS |
GB8815966D0 (en) * | 1988-07-05 | 1988-08-10 | Marconi Gec Ltd | Optical elements |
FR2646930B1 (en) * | 1989-05-12 | 1993-04-09 | Essilor Int | PROCESS FOR PRODUCING A DIFFRACTIVE ELEMENT, USABLE IN PARTICULAR IN THE MANUFACTURE OF ARTIFICIAL OPTICAL LENSES, AND LENSES THUS OBTAINED |
US5172143A (en) * | 1990-01-22 | 1992-12-15 | Essilor International Cie Generale D'optique | Artificial optical lens and method of manufacturing it |
-
1990
- 1990-05-11 FR FR9005936A patent/FR2661914B1/en not_active Expired - Fee Related
-
1991
- 1991-05-13 WO PCT/FR1991/000386 patent/WO1991018303A1/en active IP Right Grant
- 1991-05-13 ES ES91910305T patent/ES2082976T3/en not_active Expired - Lifetime
- 1991-05-13 EP EP91910305A patent/EP0486638B1/en not_active Expired - Lifetime
- 1991-05-13 AU AU79056/91A patent/AU635139B2/en not_active Ceased
- 1991-05-13 JP JP03509564A patent/JP3074296B2/en not_active Expired - Lifetime
- 1991-05-13 DE DE69115861T patent/DE69115861T2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
See references of WO9118303A1 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9839460B2 (en) | 2003-03-31 | 2017-12-12 | DePuy Synthes Products, Inc. | Remotely-activated vertebroplasty injection device |
US10039585B2 (en) | 2003-06-17 | 2018-08-07 | DePuy Synthes Products, Inc. | Methods, materials and apparatus for treating bone and other tissue |
US9918767B2 (en) | 2005-08-01 | 2018-03-20 | DePuy Synthes Products, Inc. | Temperature control system |
US9642932B2 (en) | 2006-09-14 | 2017-05-09 | DePuy Synthes Products, Inc. | Bone cement and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
WO1991018303A1 (en) | 1991-11-28 |
AU635139B2 (en) | 1993-03-11 |
EP0486638B1 (en) | 1995-12-27 |
JPH05500123A (en) | 1993-01-14 |
JP3074296B2 (en) | 2000-08-07 |
FR2661914B1 (en) | 1994-05-06 |
DE69115861T2 (en) | 1996-06-05 |
AU7905691A (en) | 1991-12-10 |
ES2082976T3 (en) | 1996-04-01 |
FR2661914A1 (en) | 1991-11-15 |
DE69115861D1 (en) | 1996-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0424520B1 (en) | Method for fabricating a transparent polymer lens with modulated refraction index | |
EP0486638B1 (en) | Method of manufacturing a lens made of transparent polymer with modulated refraction index | |
TWI712649B (en) | Soft silicone medical devices with durable lubricious coatings thereon | |
EP2268230B1 (en) | Adjustable intraocular lens | |
EP1036102A1 (en) | Method for making a transparent polymer material resistant to protein deposit, material obtained by said method, contact lenses and intraocular implants made of said material | |
US10324311B2 (en) | Visible-light photoinitiators and uses thereof | |
US9827088B2 (en) | Methods of altering the refractive index of materials | |
WO2015048035A1 (en) | Method for making uv-absorbing ophthalmic lenses | |
FR2550105A1 (en) | PROCESS FOR FORMING ABRASION-RESISTANT AND COLOR-PROOF COATING ON A SUPPORT AND ARTICLES OBTAINED THEREBY | |
CN103959103A (en) | Method of creating a visible mark on lens using a leuco dye | |
EP1068555B1 (en) | Optical system, in particular intraocular lens, contact lens | |
KR102259281B1 (en) | Contact lenses for blocking blue light and methods of manufacturing the same | |
EP0973636B1 (en) | Transparent article with radial refractive index gradient and process for its manufacture | |
FR2667073A1 (en) | Process for marking articles made of transparent organic material, such as contact lenses | |
FI96644B (en) | A volumetric phase holographic element and a method for forming it | |
US20160195735A1 (en) | Methods for tailoring the refractive index of lenses | |
EP0894099A1 (en) | Polymerizable compositions comprising a urethane oligomer as a crosslinking agent, polymers and hydrated polymers obtained using these compositions, and finished and semi-finished products manufactured using these polymers | |
JPH10148727A (en) | Forming material for optical waveguide, and optical waveguide | |
US20160195734A1 (en) | Methods of altering the refractive index of materials | |
RU2818984C2 (en) | Multifocal diffraction silicone hydrogel contact lenses | |
FR2657294A1 (en) | Method for the manufacture of an artificial optical lens, and corresponding artificial optical lens | |
FR2722308A1 (en) | METHOD AND DEVICE FOR MANUFACTURING AN OPTICAL COMPONENT | |
EP0813471A1 (en) | Method for making a transparent organic glass substrate, and resulting substrate | |
JPH02257962A (en) | Surface treatment method for eye lens | |
FR2738353A1 (en) | METHOD FOR PHOTOSENSITIZATION OF AN ALUMINOSILICATE OPTIC WAVEGUIDE AND WAVEGUIDE OBTAINED THEREBY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19920108 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): BE CH DE ES FR GB GR IT LI NL SE |
|
RBV | Designated contracting states (corrected) |
Designated state(s): BE CH DE ES FR GB IT LI NL SE |
|
17Q | First examination report despatched |
Effective date: 19940428 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): BE CH DE ES FR GB IT LI NL SE |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQU |
|
REF | Corresponds to: |
Ref document number: 69115861 Country of ref document: DE Date of ref document: 19960208 |
|
ITF | It: translation for a ep patent filed | ||
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: ESSILOR INTERNATIONAL TRANSFER- ESSILOR INTERNATIO Ref country code: CH Ref legal event code: NV Representative=s name: PATENTANWAELTE BREITER + WIEDMER AG |
|
NLT2 | Nl: modifications (of names), taken from the european patent patent bulletin |
Owner name: ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQU |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19960217 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2082976 Country of ref document: ES Kind code of ref document: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19970430 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19970521 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19970529 Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980514 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980531 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980531 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980531 |
|
BERE | Be: lapsed |
Owner name: ESSILOR INTERNATIONAL CIE GENERALE D'OPTIQUE Effective date: 19980531 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
EUG | Se: european patent has lapsed |
Ref document number: 91910305.1 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20010504 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20010510 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20010522 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20010531 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20010725 Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020513 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020514 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20021201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20021203 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20020513 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030131 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20021201 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20030611 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050513 |